ContraFect Corp Company Profile (NASDAQ:CFRXU)

About ContraFect Corp (NASDAQ:CFRXU)

ContraFect Corp logoContraFect Corporation (ContraFect ) is a biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. It intends to address drug-resistant infections using its therapeutic product candidates from its lysin and monoclonal antibody platforms to target conserved regions of either bacteria or viruses (regions that are not prone to mutation). Its product candidates are CF-301, a lysin for the treatment of Staph aureus bacteremia, and CF-404, a combination of mAbs for the treatment of life-threatening seasonal and pandemic varieties of influenza. CF-301 and CF-302 are bacteriophage lysins with potent activity against Staph aureus infections.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CFRXU
  • CUSIP: N/A
  • Web: N/A
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.74
  • P/E Growth: N/A
Dividend:
  • Dividend Yield: 1.0%
 

Frequently Asked Questions for ContraFect Corp (NASDAQ:CFRXU)

What is ContraFect Corp's stock symbol?

ContraFect Corp trades on the NASDAQ under the ticker symbol "CFRXU."

Who are some of ContraFect Corp's key competitors?

How do I buy ContraFect Corp stock?

Shares of ContraFect Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ContraFect Corp's stock price today?

One share of ContraFect Corp stock can currently be purchased for approximately $5.48.


MarketBeat Community Rating for ContraFect Corp (NASDAQ CFRXU)
Community Ranking:  3.8 out of 5 (  )
Outperform Votes:  9 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  12
MarketBeat's community ratings are surveys of what our community members think about ContraFect Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for ContraFect Corp (NASDAQ:CFRXU) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for ContraFect Corp (NASDAQ:CFRXU)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for ContraFect Corp (NASDAQ:CFRXU)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for ContraFect Corp (NASDAQ:CFRXU)
Current Year EPS Consensus Estimate: $-3.29 EPS
Next Year EPS Consensus Estimate: $-2.00 EPS

Dividends

Dividend History for ContraFect Corp (NASDAQ:CFRXU)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ContraFect Corp (NASDAQ:CFRXU)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for ContraFect Corp (NASDAQ:CFRXU)
Latest Headlines for ContraFect Corp (NASDAQ:CFRXU)
Source:

Social

Chart

ContraFect Corp (CFRXU) Chart for Friday, July, 21, 2017

This page was last updated on 7/21/2017 by MarketBeat.com Staff